Loading...
•
Jun 29
Revvity Q2 2025 Earnings Report
Revvity reported second quarter results with steady revenue growth and strong operational performance.
Key Takeaways
Revvity delivered $720 million in revenue and $53.9 million in net income during Q2 2025, outperforming expectations with disciplined execution and a robust innovation pipeline.
GAAP EPS was $0.46 and adjusted EPS came in at $1.18.
Revenue reached $720 million, showing continued growth.
Operating income rose to $90.76 million from continuing operations.
Company updated full-year guidance to reflect higher revenue expectations.
Revvity
Revvity
Revvity Revenue by Segment
Revenue by Segment
Life Sciences Revenue
CapyFin.comDiagnostics Revenue
CapyFin.com Forward Guidance
Revvity raised its full-year 2025 revenue guidance and updated adjusted EPS expectations to reflect currency changes and improved growth outlook.
Positive Outlook
- Raised full-year 2025 revenue guidance to $2.84–$2.88 billion.
- Adjusted EPS guidance increased to $4.85–$4.95.
- Organic growth forecast remains healthy at 2% to 4%.
- Strengthened by innovation pipeline and high-performing teams.
- Disciplined operational focus expected to support long-term value.
Challenges Ahead
- Adjusted EPS still below prior year for Q2.
- Operating margin slightly declined year-over-year.
- Diagnostics segment margin decreased from 27.0% to 25.2%.
- Slight reduction in adjusted operating income from last year.
- Currency headwinds impact reported revenue growth.